Comments

Iovance Biotherapeutics Stock Guidance

IOVANASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$4.21
-0.03-0.59%
Q4 2024 Earnings were released on Thu Feb 27th, after the market close
The most recent conference call was at 16:30 PM, 4 days ago Click to view past webcast
Iovance Biotherapeutics (IOVA) ForecastNewsEarningsIovance Biotherapeutics (IOVA) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Iovance Biotherapeutics Stock Guidance | NASDAQ:IOVA | Benzinga

Iovance Biotherapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Iovance Biotherapeutics (IOVA)?

A

There have been no specific sales or earnings guidance reported for Iovance Biotherapeutics in recent months.

Browse guidance and forecast on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved